Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830232 · ClinicalTrials.gov registry record · NA
Effects of Carotid Stent Design on Cerebral Embolization
A NA study, sponsored by Dallas VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00830232 is a NA study that has completed, run by Dallas VA Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT00830232, a NA study, has completed, sponsored by Dallas VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of the proposed study is to contrast the relative efficacy of closed-cell stents versus open-cell stents in preventing periprocedural cerebral embolization in high-risk patients with symptomatic and asymptomatic extracranial carotid stenosis undergoing carotid artery stenting (CAS).
Interventions
- DEVICE closed-cell stent (Xact stent)
- DEVICE Open-cell stent (Acculink carotid)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00830232
The ClinicalTrials.gov registry entry for NCT00830232 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dallas VA Medical Center, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which closed-cell stent (Xact stent) is the first listed.
NCT00830232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00830232 about?
NCT00830232 is a clinical study titled "Effects of Carotid Stent Design on Cerebral Embolization". The goal of the proposed study is to contrast the relative efficacy of closed-cell stents versus open-cell stents in preventing periprocedural cerebral embolization in high-risk patients with symptomatic and asymptomatic extracranial carotid stenosis undergoing carotid artery stenting (CAS).
What is the current status of trial NCT00830232?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2008-12. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00830232?
The interventions under investigation include: closed-cell stent (Xact stent) (DEVICE), Open-cell stent (Acculink carotid) (DEVICE).
Who is sponsoring clinical trial NCT00830232?
This trial is sponsored by Dallas VA Medical Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.